• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多巴胺 D5 受体参与 L-多巴诱导的运动障碍期间胆碱能中间神经元的激活。

The Dopamine D5 receptor contributes to activation of cholinergic interneurons during L-DOPA induced dyskinesia.

机构信息

Department of Molecular, Cellular & Biomedical Sciences, CUNY School of Medicine, New York, NY, USA.

Ph.D. Programs in Biochemistry and Biology, The Graduate Center, CUNY, New York, USA.

出版信息

Sci Rep. 2020 Feb 13;10(1):2542. doi: 10.1038/s41598-020-59011-5.

DOI:10.1038/s41598-020-59011-5
PMID:32054879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7018760/
Abstract

The dopamine D5 receptor (D5R) is a Gα-coupled dopamine receptor belonging to the dopamine D1-like receptor family. Together with the dopamine D2 receptor it is highly expressed in striatal cholinergic interneurons and therefore is poised to be a positive regulator of cholinergic activity in response to L-DOPA in the dopamine-depleted parkinsonian brain. Tonically active cholinergic interneurons become dysregulated during chronic L-DOPA administration and participate in the expression of L-DOPA induced dyskinesia. The molecular mechanisms involved in this process have not been elucidated, however a correlation between dyskinesia severity and pERK expression in cholinergic cells has been described. To better understand the function of the D5 receptor and how it affects cholinergic interneurons in L-DOPA induced dyskinesia, we used D5R knockout mice that were rendered parkinsonian by unilateral 6-OHDA injection. In the KO mice, expression of pERK was strongly reduced indicating that activation of these cells is at least in part driven by the D5 receptor. Similarly, pS6, another marker for the activity status of cholinergic interneurons was also reduced. However, mice lacking D5R exhibited slightly worsened locomotor performance in response to L-DOPA and enhanced LID scores. Our findings suggest that D5R can modulate L-DOPA induced dyskinesia and is a critical activator of CINs via pERK and pS6.

摘要

多巴胺 D5 受体(D5R)是一种 Gα 偶联多巴胺受体,属于多巴胺 D1 样受体家族。与多巴胺 D2 受体一起,它在纹状体胆碱能中间神经元中高度表达,因此有望成为多巴胺耗竭性帕金森病大脑中 L-DOPA 反应性胆碱能活动的正调节剂。在慢性 L-DOPA 给药期间,紧张性活动的胆碱能中间神经元变得失调,并参与 L-DOPA 诱导的运动障碍的表达。然而,这个过程中涉及的分子机制尚未阐明,但是已经描述了运动障碍严重程度与胆碱能细胞中 pERK 表达之间的相关性。为了更好地理解 D5 受体的功能以及它如何影响 L-DOPA 诱导的运动障碍中的胆碱能中间神经元,我们使用了单侧 6-OHDA 注射致帕金森病的 D5R 敲除小鼠。在 KO 小鼠中,pERK 的表达强烈减少,表明这些细胞的激活至少部分是由 D5 受体驱动的。同样,pS6,另一种胆碱能中间神经元活性状态的标志物,也减少了。然而,缺乏 D5R 的小鼠在 L-DOPA 反应中表现出稍微恶化的运动性能和增强的 LID 评分。我们的发现表明,D5R 可以调节 L-DOPA 诱导的运动障碍,并且通过 pERK 和 pS6 是 CINs 的关键激活剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd78/7018760/3c1c5ea3a7a2/41598_2020_59011_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd78/7018760/6a18eb1b2cea/41598_2020_59011_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd78/7018760/c75125f27e6c/41598_2020_59011_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd78/7018760/593d9c850814/41598_2020_59011_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd78/7018760/5b841666cbb5/41598_2020_59011_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd78/7018760/3c1c5ea3a7a2/41598_2020_59011_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd78/7018760/6a18eb1b2cea/41598_2020_59011_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd78/7018760/c75125f27e6c/41598_2020_59011_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd78/7018760/593d9c850814/41598_2020_59011_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd78/7018760/5b841666cbb5/41598_2020_59011_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd78/7018760/3c1c5ea3a7a2/41598_2020_59011_Fig5_HTML.jpg

相似文献

1
The Dopamine D5 receptor contributes to activation of cholinergic interneurons during L-DOPA induced dyskinesia.多巴胺 D5 受体参与 L-多巴诱导的运动障碍期间胆碱能中间神经元的激活。
Sci Rep. 2020 Feb 13;10(1):2542. doi: 10.1038/s41598-020-59011-5.
2
CK2 Oppositely Modulates l-DOPA-Induced Dyskinesia via Striatal Projection Neurons Expressing D1 or D2 Receptors.蛋白激酶CK2通过表达D1或D2受体的纹状体投射神经元对左旋多巴诱导的异动症产生相反调节作用。
J Neurosci. 2017 Dec 6;37(49):11930-11946. doi: 10.1523/JNEUROSCI.0443-17.2017. Epub 2017 Nov 2.
3
Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation.多巴胺D1受体而非D2受体的基因失活可抑制左旋多巴诱导的运动障碍和组蛋白激活。
Biol Psychiatry. 2009 Sep 15;66(6):603-13. doi: 10.1016/j.biopsych.2009.04.025. Epub 2009 Jun 11.
4
A new outlook on cholinergic interneurons in Parkinson's disease and L-DOPA-induced dyskinesia.帕金森病和 L-DOPA 诱导性运动障碍中胆碱能中间神经元的新观点。
Neurosci Biobehav Rev. 2018 Sep;92:67-82. doi: 10.1016/j.neubiorev.2018.05.021. Epub 2018 May 18.
5
Enhanced histamine H2 excitation of striatal cholinergic interneurons in L-DOPA-induced dyskinesia.左旋多巴诱导的运动障碍中纹状体胆碱能中间神经元组胺H2兴奋性增强。
Neurobiol Dis. 2015 Apr;76:67-76. doi: 10.1016/j.nbd.2015.01.003. Epub 2015 Feb 4.
6
D1/D5 Inverse Agonists Restore Striatal Cholinergic Interneuron Physiology in Dyskinetic Mice.D1/D5 反向激动剂可恢复运动障碍小鼠纹状体内胆硷能中间神经元的生理功能。
Mov Disord. 2022 Aug;37(8):1693-1706. doi: 10.1002/mds.29055. Epub 2022 May 9.
7
L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice.L-DOPA 治疗选择性地恢复了运动障碍小鼠中表达多巴胺受体 D2 的投射神经元中的棘密度。
Biol Psychiatry. 2014 May 1;75(9):711-22. doi: 10.1016/j.biopsych.2013.05.006. Epub 2013 Jun 13.
8
Genetic deletion of GPR88 enhances the locomotor response to L-DOPA in experimental parkinsonism while counteracting the induction of dyskinesia.遗传敲除 GPR88 增强了实验性帕金森病对 L-DOPA 的运动反应,同时抵消了不自主运动的诱导。
Neuropharmacology. 2020 Jan 1;162:107829. doi: 10.1016/j.neuropharm.2019.107829. Epub 2019 Oct 24.
9
Effects of 5-HT1A receptor stimulation on striatal and cortical M1 pERK induction by L-DOPA and a D1 receptor agonist in a rat model of Parkinson's disease.5-HT1A 受体刺激对帕金森病大鼠模型中 L-DOPA 和 D1 受体激动剂诱导纹状体和皮质 M1 pERK 的影响。
Brain Res. 2013 Nov 6;1537:327-39. doi: 10.1016/j.brainres.2013.09.020. Epub 2013 Sep 21.
10
BDNF/TrkB pathway activation in D1 receptor-expressing striatal projection neurons plays a protective role against L-DOPA-induced dyskinesia.D1 受体表达的纹状体投射神经元中 BDNF/TrkB 通路的激活对左旋多巴诱导的运动障碍发挥保护作用。
Neurobiol Dis. 2023 Sep;185:106238. doi: 10.1016/j.nbd.2023.106238. Epub 2023 Jul 24.

引用本文的文献

1
Interaction Between Oxytocin and Dopamine Signaling: Focus on the Striatum.催产素与多巴胺信号之间的相互作用:聚焦于纹状体。
Int J Mol Sci. 2025 Sep 6;26(17):8711. doi: 10.3390/ijms26178711.
2
Extrinsic and intrinsic control of striatal cholinergic interneuron activity.纹状体胆碱能中间神经元活动的外在和内在控制。
Front Mol Neurosci. 2025 Feb 13;18:1528419. doi: 10.3389/fnmol.2025.1528419. eCollection 2025.
3
State-dependent modulation of spiny projection neurons controls levodopa-induced dyskinesia in a mouse model of Parkinson's disease.

本文引用的文献

1
The striatal cholinergic system in L-dopa-induced dyskinesias.纹状体胆碱能系统在左旋多巴诱导的运动障碍中的作用。
J Neural Transm (Vienna). 2018 Aug;125(8):1251-1262. doi: 10.1007/s00702-018-1845-9. Epub 2018 Feb 28.
2
CK2 Oppositely Modulates l-DOPA-Induced Dyskinesia via Striatal Projection Neurons Expressing D1 or D2 Receptors.蛋白激酶CK2通过表达D1或D2受体的纹状体投射神经元对左旋多巴诱导的异动症产生相反调节作用。
J Neurosci. 2017 Dec 6;37(49):11930-11946. doi: 10.1523/JNEUROSCI.0443-17.2017. Epub 2017 Nov 2.
3
The Dopamine D5 Receptor Is Involved in Working Memory.
帕金森病小鼠模型中,棘状投射神经元的状态依赖性调节控制左旋多巴诱发的异动症。
bioRxiv. 2025 Jan 7:2025.01.02.631090. doi: 10.1101/2025.01.02.631090.
4
Risperidone Decreases Expression of Serotonin Receptor-2A (5-HT2A) and Serotonin Transporter (SERT) but Not Dopamine Receptors and Dopamine Transporter (DAT) in PBMCs from Patients with Schizophrenia.利培酮降低精神分裂症患者外周血单核细胞中5-羟色胺受体2A(5-HT2A)和5-羟色胺转运体(SERT)的表达,但不影响多巴胺受体和多巴胺转运体(DAT)的表达。
Pharmaceuticals (Basel). 2024 Jan 28;17(2):167. doi: 10.3390/ph17020167.
5
Dopamine Signaling in Substantia Nigra and Its Impact on Locomotor Function-Not a New Concept, but Neglected Reality.黑质多巴胺信号及其对运动功能的影响——并非新概念,而是被忽视的现实。
Int J Mol Sci. 2024 Jan 17;25(2):1131. doi: 10.3390/ijms25021131.
6
The dual role of striatal interneurons: circuit modulation and trophic support for the basal ganglia.纹状体中间神经元的双重作用:对基底神经节的回路调节和营养支持。
Neural Regen Res. 2024 Jun 1;19(6):1277-1283. doi: 10.4103/1673-5374.382987. Epub 2023 Aug 14.
7
Dopamine agonists in Parkinson's disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment.帕金森病中的多巴胺激动剂:D1样或D2样多巴胺受体亚型选择性的影响及未来治疗途径
Clin Park Relat Disord. 2023 Jul 7;9:100212. doi: 10.1016/j.prdoa.2023.100212. eCollection 2023.
8
The changing landscape of agriculture: role of precision breeding in developing smart crops.农业格局的变化:精准育种在发展智慧作物中的作用。
Funct Integr Genomics. 2023 May 19;23(2):167. doi: 10.1007/s10142-023-01093-1.
9
Rationale and Development of Tavapadon, a D1/D5-Selective Partial Dopamine Agonist for the Treatment of Parkinson's Disease.Tavapadon,一种用于治疗帕金森病的 D1/D5-选择性部分多巴胺激动剂的研发背景。
CNS Neurol Disord Drug Targets. 2024;23(4):476-487. doi: 10.2174/1871527322666230331121028.
10
D2R signaling in striatal spiny neurons modulates L-DOPA induced dyskinesia.纹状体棘状神经元中的D2R信号传导调节左旋多巴诱导的运动障碍。
iScience. 2022 Oct 4;25(10):105263. doi: 10.1016/j.isci.2022.105263. eCollection 2022 Oct 21.
多巴胺D5受体参与工作记忆。
Front Pharmacol. 2017 Oct 6;8:666. doi: 10.3389/fphar.2017.00666. eCollection 2017.
4
Chemogenetic modulation of cholinergic interneurons reveals their regulating role on the direct and indirect output pathways from the striatum.化学遗传学调节胆碱能中间神经元揭示了它们对纹状体直接和间接输出通路的调节作用。
Neurobiol Dis. 2018 Jan;109(Pt A):148-162. doi: 10.1016/j.nbd.2017.10.010. Epub 2017 Oct 14.
5
Activation of DRD5 (dopamine receptor D5) inhibits tumor growth by autophagic cell death.DRD5(多巴胺受体 D5)的激活通过自噬性细胞死亡抑制肿瘤生长。
Autophagy. 2017 Aug 3;13(8):1404-1419. doi: 10.1080/15548627.2017.1328347. Epub 2017 Jun 14.
6
Optogenetic activation of striatal cholinergic interneurons regulates L-dopa-induced dyskinesias.纹状体胆碱能中间神经元的光遗传学激活可调节左旋多巴诱发的运动障碍。
Neurobiol Dis. 2016 Jul;91:47-58. doi: 10.1016/j.nbd.2016.02.019. Epub 2016 Feb 24.
7
Activation of D1/5 Dopamine Receptors: A Common Mechanism for Enhancing Extinction of Fear and Reward-Seeking Behaviors.D1/5多巴胺受体的激活:增强恐惧消退和奖赏寻求行为的共同机制。
Neuropsychopharmacology. 2016 Jul;41(8):2072-81. doi: 10.1038/npp.2016.5. Epub 2016 Jan 14.
8
M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia.M4毒蕈碱受体信号传导改善左旋多巴诱导的异动症模型中的纹状体可塑性缺陷。
Neuron. 2015 Nov 18;88(4):762-73. doi: 10.1016/j.neuron.2015.10.039.
9
Dopamine D3 Receptor Modulates l-DOPA-Induced Dyskinesia by Targeting D1 Receptor-Mediated Striatal Signaling.多巴胺 D3 受体通过靶向 D1 受体介导的纹状体信号传导来调节左旋多巴诱导的异动症。
Cereb Cortex. 2017 Jan 1;27(1):435-446. doi: 10.1093/cercor/bhv231.
10
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.帕金森病中左旋多巴诱导的运动和非运动并发症的病理生理学。
Prog Neurobiol. 2015 Sep;132:96-168. doi: 10.1016/j.pneurobio.2015.07.002. Epub 2015 Jul 21.